News about Biotechnology

NPPA fixes retail prices of 14 formulations under DPCO 2013

NPPA fixes retail prices of 14 formulations under DPCO 2013

NPPA has fixed retail prices of 14 formulations under Drugs Prices Control Order (DPCO)- 2013 relating to 76th Authority meeting dated June 22, 2020<br />

Biotechnology | 03/07/2020 | By Darshana

Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1

Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1

AstraZeneca today announced that selumetinib has been granted orphan drug designation (ODD) in Japan for the treatment of neurofibromatosis type 1 (NF1), a rare and debilitating genetic disease

Biotechnology | 01/07/2020 | By Darshana

'COVAXIN': India's first Covid vaccine gets DGCI's approval for clinical trials

'COVAXIN': India's first Covid vaccine gets DGCI's approval for clinical trials

Bharat Biotech, has successfully developed Covaxin, India?s 1st vaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech

Biotechnology | 30/06/2020 | By Darshana

Hetero Healthcare set to supply 20,000 vials of generic remdesivir across country

Hetero Healthcare set to supply 20,000 vials of generic remdesivir across country

Following the approval of ?Covifor?, the generic of remdesivir by DCGI, Hetero Healthcare Limited, a group company of Hetero is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each

Biotechnology | 25/06/2020 | By Darshana

Novartis discontinues hydroxychloroquine trial for COVID-19 due to acute enrollment challenges

Novartis discontinues hydroxychloroquine trial for COVID-19 due to acute enrollment challenges

Novartis has made the decision to stop and discontinue its sponsored hydroxychloroquine(HCQ) clinical trial for COVID-19 due to acute enrollment challenges that have made trial completion infeasible

Biotechnology | 22/06/2020 | By Darshana

Merck Animal Health acquires leading data and analytics company, Quantified Ag to broaden livestock digital portfolio

Merck Animal Health acquires leading data and analytics company, Quantified Ag to broaden livestock digital portfolio

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, announced the completion of its acquisition of Quantified Ag, a leading data and analytics company that monitors cattle body temperature and movement in order to detect illness early

Biotechnology | 19/06/2020 | By Darshana

Neurocrine, Takeda collaborate to develop and commercialise potential therapies for psychiatric disorders

Neurocrine, Takeda collaborate to develop and commercialise potential therapies for psychiatric disorders

Neurocrine Biosciences Inc and Takeda Pharmaceutical Company Limited announced a strategic collaboration to develop and commercialise compounds in Takeda?s early-to-mid-stage psychiatry pipeline. Specifically, Takeda granted an exclusive license to Neurocrine Biosciences for seven pipeline programmes, including three clinical stage assets

Biotechnology | 18/06/2020 | By Darshana

Bayer extends clinical development program for finerenone with Phase III study in patients with heart failure and preserved ejection fraction

Bayer extends clinical development program for finerenone with Phase III study in patients with heart failure and preserved ejection fraction

Bayer announced today the initiation of the FINEARTS-HF study, a multicenter, randomized, double-blind, placebo-controlled Phase III study to evaluate the efficacy and safety of finerenone on morbidity and mortality in patients suffering from symptomatic heart failure

Biotechnology | 16/06/2020 | By Darshana

Cipla releases batch of 700 tocilizumab injections to Gujarat FDCA to address growing demand for treatment of COVID-19 patients

Cipla releases batch of 700 tocilizumab injections to Gujarat FDCA to address growing demand for treatment of COVID-19 patients

Following National Pharmaceutical Pricing Authority (NPPA) directive to address the demand of tocilizumab injection in government hospitals in Gujarat for the treatment of COVID-19 patients, the Mumbai-based pharmaceutical major Cipla Ltd has renewed its supply by releasing another batch of 700 tocilizumab injections to Gujarat

Biotechnology | 11/06/2020 | By Darshana

Lupin: U.S. FDA Grants Mexiletine Orphan Drug Designation

Lupin: U.S. FDA Grants Mexiletine Orphan Drug Designation

Pharma major Lupin Limited (Lupin) is announced today that the US Food and Drug Administration (U.S. FDA) has granted Orphan Drug Designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders

Biotechnology | 08/06/2020 | By Darshana

 
 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology